Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
130,139,458
-
Shares change
-
+22,884,334
-
Total reported value, excl. options
-
$484,243,395
-
Value change
-
+$81,897,100
-
Put/Call ratio
-
80.74%
-
Number of buys
-
87
-
Number of sells
-
-52
-
Price
-
$3.72
Significant Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q4 2021
205 filings reported holding CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock as of Q4 2021.
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 130,139,458 shares
of 416,598,522 outstanding shares and own 31.24% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (25,887,351 shares), GREENOAKS CAPITAL PARTNERS LLC (24,847,610 shares), BAILLIE GIFFORD & CO (7,787,680 shares), TWO SIGMA INVESTMENTS, LP (6,609,628 shares), PNC Financial Services Group, Inc. (6,361,917 shares), BlackRock Inc. (5,351,416 shares), Ghisallo Capital Management LLC (5,297,006 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (5,052,286 shares), TWO SIGMA ADVISERS, LP (4,378,700 shares), and CITADEL ADVISORS LLC (3,589,146 shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.